Jeremy M. Levin

Executive Chairman of the Board

CEO Chairman Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir Executive Chairman and Former Chief Executive Officer	$644,054	—	—	$744,645	$532,000	$14,000	$1,934,699
2024	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir Chief Executive Officer	$625,296	—	—	$1,842,680	$292,326	$13,800	$2,774,102
2023	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir Chief Executive Officer	$596,965	—	—	$1,106,520	$390,810	$13,200	$2,107,495
2022	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir Chief Executive Officer	$607,083	—	—	$2,204,217	$303,542	$12,920	$3,127,762
2021	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir Chief Executive Officer	$583,734	—	—	—	$251,735	$11,600	$847,069
2020	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir. Chief Executive Officer	$560,000	—	—	$1,274,260	$280,000	$21,239	$2,135,499
2019	Ovid Therapeutics Inc. (OVID)	DPhil, MB BChir. Chief Executive Officer	$530,450	—	—	$2,187,660	$265,225	$25,645	$3,008,980

Earnings-call appearances

No earnings-call appearances recorded yet.